Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_assertion type Assertion NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_head.
- NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_assertion description "[Bone metastases (BMs) are associated with poor outcome in metastatic clear-cell renal carcinoma (m-ccRCC) treated with anti-vascular endothelial growth factor tyrosine kinase inhibitors (anti-VEGFR-TKIs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_provenance.
- NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_assertion evidence source_evidence_literature NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_provenance.
- NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_assertion SIO_000772 26528707 NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_provenance.
- NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_assertion wasDerivedFrom befree-2016 NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_provenance.
- NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_assertion wasGeneratedBy ECO_0000203 NP1295382.RAdMRmytWk9KbLljS7hEu2ch0oJEpjzAMlMMTWwZ9fdsA130_provenance.